HANSEATIC MANAGEMENT SERVICES INC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANSEATIC MANAGEMENT SERVICES INC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2015$310,000
-5.5%
12,305
+4.7%
0.14%
-22.2%
Q1 2015$328,000
+53.3%
11,751
+0.0%
0.18%
+60.0%
Q4 2014$214,00011,7480.11%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders